Search results
Wall Street Analysts Believe Prometheus Biosciences, Inc. (RXDX) Could Rally 26.51%: Here's is How...
Zacks via Yahoo Finance· 1 year agoThe average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in...
What Makes Prometheus Biosciences, Inc. (RXDX) a New Buy Stock
Zacks via Yahoo Finance· 2 years agoPrometheus Biosciences, Inc. (RXDX) might move higher on growing optimism about its earnings...
Prometheus Biosciences, Inc. (RXDX) is a Great Momentum Stock: Should You Buy?
Zacks via Yahoo Finance· 1 year agoMomentum investing revolves around the idea of following a stock's recent trend in either direction....
Prometheus Biosciences, Inc. (RXDX) Stock Jumps 69.7%: Will It Continue to Soar?
Zacks via Yahoo Finance· 1 year agoPrometheus Biosciences, Inc. (RXDX) was a big mover last session on higher-than-average trading...
Prometheus Biosciences (NASDAQ:RXDX) pulls back 15% this week, but still delivers shareholders...
Simply Wall St. via Yahoo Finance· 2 years agoIt's been a soft week for Prometheus Biosciences, Inc. (NASDAQ:RXDX) shares, which are down 15%. But...
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom
Investor's Business Daily· 1 year agoMerck is acquiring immunology-focused drugmaker Prometheus Bio in a well-timed $10.8 billion deal...
With 67% ownership, Prometheus Biosciences, Inc. (NASDAQ:RXDX) boasts of strong institutional...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Institutions' substantial holdings in Prometheus Biosciences implies that they have...
Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck
Zacks via Yahoo Finance· 1 year agoPrometheus (RXDX) is set to be acquired by Merck for $11 billion, adding Prometheus' lead product...
Prometheus Biosciences, Inc. (RXDX) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoPrometheus Biosciences, Inc. (RXDX) delivered earnings and revenue surprises of 6.52% and 81.29%,...
Zacks Investment Ideas feature highlights: XBI, Catalyst Pharma, Prometheus Biosciences, Sage...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – January 16, 2023 – Today, Zacks Investment Ideas feature...
